ORODISPERSIBLE TABLETTE ENTHALTEND ESTETROL

European patent · EP3310345 · In force

Register entry

Publication number
EP3310345
Application number
EP16729601
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 17, 2016
Published
Apr 25, 2018
Granted
Mar 31, 2021
Protection ends at the latest
Jun 16, 2036
Next annual fee due
Jun 30, 2027
IPC classes
A61K 9/20 (2006.01)
A61K 31/565 (2006.01)
A61P 5/30 (2006.01)
A61P 15/18 (2006.01)
Priority
EP 15172751 18.06.2015
PCT application
PCT/EP2016/064071 17.06.2016
PCT publication
WO2016/203009 22.12.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. Jul 1, 2024

    Change

    Published in Swissreg on 01.07.2024

  4. Jul 1, 2023

    Change

    Published in Swissreg on 01.07.2023

  5. Jul 1, 2022

    Change

    Published in Swissreg on 01.07.2022

  6. Feb 9, 2022

    Change

    Published in Swissreg on 09.02.2022

  7. May 5, 2021

    Agent entered

    Representative
    Ing. Marco Zardi, c/o M. ZARDI & Co. S.A., via Pioda 6, 6900 Lugano

    Published in Swissreg on 05.05.2021

  8. Mar 31, 2021

    Granted

    Published in Swissreg on 31.03.2021

Parties

Inventor

PLATTEEUW, Johannes Jan

5283 JH Boxtel, NL

VAN DEN HEUVEL, Denny Johan Marijn

6642 DJ Beuningen, NL

JASPART, Séverine Francine Isabelle

4560 Bois-et-Borsu, BE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.